INTRODUCTION {#S1}
============

Epithelia that line internal cavities have several important specialised functions. Such epithelia include the mucosal epithelia of the gut, the mucociliary epithelia of the lung and the secretory epithelia of the kidney. Although their predominant function differs in each case, all of these epithelia have two properties in common: they consist of several different cell types that cooperate to perform the epithelium's primary function, and they are required to act as a protective barrier for internal tissues.

A number of human diseases arise due to damaged or defective mucosal or mucociliary epithelia and they are usually caused by a defect in one of the many cell types that comprise the epithelial tissue. However, this primary defect can have an impact on adjacent cell types, compromising the function of the epithelium as a whole. This is exemplified by cystic fibrosis in the respiratory epithelium and the gut. The cystic fibrosis transmembrane conductance regulator (CFTR), a chloride/bicarbonate transporter, is principally found in serous acinar cells in the submucosal glands of the lungs ([@R11]). However, mutations in this channel can have indirect effects on neighbouring cells by affecting ionic homeostasis, making mucus thick and sticky and inhibiting clearance by cilia ([@R20]). In the gut, CFTR is present in enterocytes but it has been hypothesised that intercellular communication with adjacent goblet cells can affect secretion of mucins through alterations in levels of bicarbonate ([@R13]). Thus, understanding how different cell types interact, and the role that each one plays in the integrity of the epithelium, is of paramount importance for understanding the underlying aetiology of epithelial disease.

Epithelial models that are reconstituted *in vitro* tend not to recapitulate the complexity that exists *in vivo*, but experiments in mammalian models are difficult, invasive and expensive. For these reasons, model systems of lower vertebrates, where such epithelia can be readily accessed, have been instrumental in advancing our understanding of mucociliary epithelial development. In recent years, the larval skin of *Xenopus* has been extensively studied because it is known to have a population of motile multiciliated cells ([@R7]). Indeed, research into the ciliated cells in the epidermis of *Xenopus* embryos has yielded a number of important insights that are relevant across different biological systems and disease ([@R6]; [@R33]; [@R38]; [@R51]). For example, the PCP protein, Fritz, has been shown to be crucial in controlling the localisation of the cytoskeletal Septin proteins to the base of cilia ([@R27]). The same study identified mutations in the human Fritz gene in patients suffering from ciliopathies such as Bardet-Biedl syndrome. This illustrates how findings in a model organism such as *Xenopus* can have direct clinical relevance.

However, if the embryonic *Xenopus* epidermis is to be a truly powerful model of mucociliary and mucosal epithelia, it is necessary to understand and characterise all cell types that comprise it. With this in mind, we, and others, have recently identified the ionocytes. Ionocytes tend to appear in close proximity to the ciliated cells in the larval epidermis and they have a number of pumps and channels involved in regulating ionic balance and pH ([@R8]; [@R40]). Similar cells are found in human mucosal epithelia, such as the serous cells in the respiratory tract ([@R31]) and the enterocytes of the gut ([@R13]). Depletion of these cells in the *Xenopus* embryonic epidermis caused a defect in the localisation of basal bodies of neighbouring ciliated cells. This is likely to be due to alteration in pH across the epidermis, which is known to affect the localisation of Dishevelled, a basal body interacting protein ([@R38]; [@R45]). These findings confirm the power of a multicellular model system in uncovering previously unknown cell-cell interactions that take place *in vivo*.

The *Xenopus* larval epidermis also contains 'goblet cells' that make up the majority of the epithelium and were originally described at an ultrastructural level in electron micrographs ([@R3]). It is generally assumed that they secrete mucins, like their mammalian counterparts; however, no specific mucins have ever been identified in secretions from these vesicles. They are known to secrete a lectin, Xeel, which is proposed to recognise pathogen-associated glycans ([@R35]). The glycosaminoglycan, chondroitin sulphate, has also been identified in the goblet cells but its function is not clear ([@R36]).

In this study, we identify and characterise an additional cell type in the larval epidermis of *Xenopus tropicalis*. This cell type is small and contains an abundance of large apical secretory vesicles. We adopt the term small secretory cells (SSCs), which has been previously used for cells of similar ultrastructural morphology but unknown function ([@R17]). Our data suggest that SSCs are specified by Foxa1, secrete a dense, heavily glycosylated material, are responsible for the innate defence mechanisms of the embryo against pathogen invasion, and complete the characterisation of the embryonic epidermis.

RESULTS {#S2}
=======

Identification of a new epidermal cell type {#S3}
-------------------------------------------

The larval *Xenopus* embryonic epidermis has been shown to contain at least three cell types: ciliated cells, ionocytes and goblet cells ([@R8]). To investigate whether there are additional cell types, we combined double fluorescent *in situ* hybridisation using a probe for ciliated cells (*α-1-tubulin*) and a probe for ionocytes (*atp6v1a*), with antibody staining for goblet cells (anti-Xeel) and the nuclear marker, DAPI, at late tailbud stages (stage 32). As [Fig. 1A](#F1){ref-type="fig"} shows, these three cell types do not account for all of the cells in the epidermis and there is at least one more cell type present (examples in yellow circles).

![***foxa1* marks a new epidermal cell type.** (A) Double fluorescence *in situ* hybridisation and antibody staining for a ciliated cell marker (*α-1-tubulin*, red), an ionocyte marker (*atp6v1a*, green) and a goblet cell marker (anti-Xeel, grey) on stage 32 embryos. DAPI (blue) is used to mark each cell. At least one cell type (yellow circles) is not stained by these markers. (B) Chromogenic *in situ* hybridisation for *foxa1* on stage 25 embryos shows scattered, spotted epidermal distribution. (C) *foxa1* is epidermally expressed in a subset of DAPI-positive cells. (D) *foxa1* expression (grey) completes the epidermal staining when added to markers of the other cell types at stage 32. Scale bars: 20 μm in A,C,D; 500 μm in B.](DEV102426F1){#F1}

*Foxa1* was previously shown to be expressed in a scattered, spotted epidermal distribution by *in situ* hybridisation in *Xenopus laevis* ([@R17]) and we confirmed this in *X. tropicalis* ([Fig. 1B](#F1){ref-type="fig"}). Combining *foxa1* with the markers of the other cell types showed that *foxa1* is expressed in the remaining cell type ([Fig. 1C,D](#F1){ref-type="fig"}). With *foxa1* included, no further gaps were present in the staining ([Fig. 1D](#F1){ref-type="fig"}), which led us to conclude that the *foxa1*-positive cells complete the composition of the outer epidermal layer at late tailbud stages. But what are these cells and how do they arise?

The *foxa1*-expressing cell type intercalates into the outer layer at mid-tailbud stages {#S4}
----------------------------------------------------------------------------------------

The epidermal expression of *foxa1* begins after the onset of *foxj1* and *foxi1* expression in ciliated cells and ionocytes, respectively, at about stage 13-14 ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S1). Meanwhile, combining markers for ciliated cells, ionocytes and goblet cells at mid-tailbud stages (stage 25) showed that all the outer layer cells are accounted for (data not shown), whereas at late tailbud stages they are not ([Fig. 1A](#F1){ref-type="fig"}). This led us to hypothesise that the *foxa1*-positive cell type intercalates into the outer layer, like ciliated cells ([@R6]) and ionocytes ([@R8]), but at a later time point.

Indeed, *foxa1* expression changes from inner to outer layer between early and late tailbud stages ([Fig. 2A](#F2){ref-type="fig"}). When performing a transplant of a micro-ruby (MR)-labelled piece of outer layer of one embryo onto a fluorescein-dextran (FLDX)-labelled inner layer of another at gastrula stages (see Materials and methods), there is clearly a cell type (marked by yellow arrows) that intercalates into the outer layer in addition to ciliated cells (anti-AcTub antibody, blue) and ionocytes (anti-V1a, white) by stage 32 ([Fig. 2B](#F2){ref-type="fig"}). To see if *foxa1* cells do indeed intercalate, we transplanted an FLDX-labelled piece of outer layer of one embryo onto a Cascade Blue (CB)-labelled inner layer of another and allowed to develop until stage 32 before labelling with a *foxa1* probe. *Foxa1*-labelled cells colocalise with CB cells and thus must originate from the inner layer ([Fig. 2C](#F2){ref-type="fig"}). To check for the origin of goblet cells, we transplanted a piece of outer layer from one embryo (FLDX) onto the inner layer (MR) of another and reared until stage 32. The goblet cell marker, anti-Xeel shows colocalisation with FLDX, and hence the goblet cells must differentiate from the original outer layer cells ([Fig. 2D](#F2){ref-type="fig"}).

![***foxa1* cells intercalate from inner to outer layer at mid-tailbud stages.** (A) Sections of stage 22 and stage 32 embryos stained for DAPI (blue) and *foxa1* (red) by fluorescent *in situ* hybridisation shows that expression changes from inner to outer layer as the embryo develops. (B) Transplant of MR-labelled (red) outer layer epidermal tissue on to FLDX-labelled (green) host embryo and stained using antibodies for ciliated cell marker, acetylated α-tubulin (AcTub, blue) and ionocyte marker, V1a (grey) at stage 32. A cell type (yellow arrows) intercalates from inner to outer layer in addition to ciliated cells and ionocytes. (C) Transplant of FLDX-labelled (green) outer layer epidermal tissue on to CB-labelled (blue) host embryo and stained by fluorescent *in situ* hybridisation for *foxa1* (red) at stage 32. (D) Transplant of FLDX-labelled (green) outer layer epidermal tissue on to MR-labelled (red) host embryo and stained with anti-Xeel antibody (blue). Scale bars: 50 μm in A,B,D; 15 μm in C.](DEV102426F2){#F2}

The new cell type is small with large apical secretory vesicles {#S5}
---------------------------------------------------------------

Using membrane-GFP and co-staining with markers for ciliated cells, ionocytes and goblet cells, we were able to determine the distinct morphology of these cells. This new cell type is small in size compared with its neighbours but contains large apical openings at the surface, evident with mGFP staining and by scanning electron microscopy (SEM; [Fig. 3](#F3){ref-type="fig"}). The SEM image shows 'pores' (average diameter of 1.3±0.09 μm) on the surface of this cell type, which are likely to correspond to vesicles that have opened out to release their content (arrow highlights possible secretory material on the surface). Images obtained by transmission electron microscopy (TEM; [Fig. 3B](#F3){ref-type="fig"}), showed an abundance of large vesicles at the apical membrane. Other vesicles, which are presumably immature, were evident deeper within the cell (yellow arrow). Magnification of the apical vesicles showed that they contain material with a dark, presumably dense, core surrounded by lighter material. A comparison with earlier studies of the *X. laevis* embryonic epidermis showed that these cells have been described by their morphology before ([@R17]; [@R34]). Owing to their size and apparent function, these cells were defined as small secretory cells (SSCs), a nomenclature retained here.

![**Small cells with large vesicles containing secretory material.** (A) Small cells (yellow circles) are not labelled by markers for ciliated cells (anti-AcTub), ionocytes (anti-V1a) or goblet cells (anti-Xeel). Membranes are marked with membrane GFP (mGFP). (B) SEM shows small cells with large apical openings and secretory material highlighted with an arrow. Sections imaged by TEM show vesicles at the apical membrane containing a dark core surrounded by lighter material. Highlighted with a yellow arrow is a vesicle deeper within the cytoplasm that may represent an immature vesicle. Scale bars: in A, 10 μm; in B, 2 μm (SEM), 1 μm (TEM, low magnification) and 0.5 μm (TEM, high magnification).](DEV102426F3){#F3}

SSCs contain a number of different proteins including glycoproteins {#S6}
-------------------------------------------------------------------

The mRNA for inositol trisphosphate kinase b (*itpkb*), an enzyme that catalyses the conversion of IP~3~ to IP~4~ and is involved in calcium signalling,~,~ is known to have a scattered, punctate epidermal expression pattern in *Xenopus* ([@R49]) and we confirmed this here ([Fig. 4A](#F4){ref-type="fig"}). To see if *itpkb* is expressed in SSCs, we tested for colocalisation with *foxa1* by double *in situ* hybridisation and found complete overlap ([Fig. 4B](#F4){ref-type="fig"}). Like *foxa1, itpkb* did not colocalise with markers for the other cell types ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S2). An antibody generated against Itpkb showed localisation in or around the secretory vesicles of the SSCs ([Fig. 4C](#F4){ref-type="fig"}). The material in these vesicles was also recognised by peanut agglutinin (PNA), a lectin that binds the carbohydrate sequence Gal-β(1-3)-GalNAc ([Fig. 4D,E](#F4){ref-type="fig"}). PNA was originally shown to bind to material in the epidermis of *X. laevis* ([@R46]); however, the cell types that secrete it were not defined. Here, we show that they are *foxa1*-expressing cells ([Fig. 4D](#F4){ref-type="fig"}). PNA also recognised material in the vesicles of goblet cells, but at a much lower level than the SSCs ([Fig. 4E](#F4){ref-type="fig"}, yellow arrow). In addition to the epidermal staining, PNA stained material secreted from the cement gland, which is also positive for a mucin, *muc5e* ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S3).

![**Molecular profile of the new cell type.** (A) *In situ* hybridisation using an antisense probe to the *itpkb* transcript reveals a scattered, punctate epidermal pattern. (B) Double fluorescence *in situ* hybridisation for *foxa1* and *itpkb* shows colocalisation of the two transcripts. (C) Antibody staining for Itpkb with mGFP shows localisation in the small cells with large apical vesicles. (D) PNA conjugated to Alexa Fluor-568 colocalises with *foxa1*. (E) PNA together with mGFP staining shows strong labelling of material in the large vesicles. Staining is also evident at a lower level in vesicles of goblet cells (yellow arrow). (F) Antibody staining to the carbohydrate epitope HNK-1 together with mGFP shows specific expression in the vesicles of the small cells. (G) Co-staining for HNK-1 and PNA shows that they are present in the same cell. Scale bars: 500 μm in A; 50 μm in B; 5 μm in C,E-G; 15 μm in D.](DEV102426F4){#F4}

Another carbohydrate epitope, HNK-1 (HSO~3~-3GlcAβ1-3Galβ1-4GlcNAc), also showed staining in a subset of epidermal cells in a previous study, but again the cell type was not properly defined ([@R47]). Using a monoclonal antibody we found some vesicles in SSCs were highly positive for HNK-1 ([Fig. 4F](#F4){ref-type="fig"}). PNA and HNK-1 tend to be found in different vesicles ([Fig. 4G](#F4){ref-type="fig"}). However, other cells showed some colocalisation between the two markers (data not shown). Therefore, it is difficult to say at this stage if they represent distinct molecular species or perhaps, different stages of maturation.

Foxa1 is a regulator of SSC development {#S7}
---------------------------------------

By analogy to the regulation of ionocytes by Foxi1 ([@R8]) and ciliated cells by Foxj1 ([@R50]; [@R61]), we hypothesised that Foxa1 may have a role in the development of SSCs. To test this, we knocked down *foxa1* with a morpholino targeting the splice junction of the exon-1-intron 1 boundary ([Fig. 5A](#F5){ref-type="fig"}). Using cell type-specific markers, we found that there was no change in the number of ciliated cells or goblet cells, but there was a large decrease in the number of SSCs (61% reduction; [Fig. 5B](#F5){ref-type="fig"}). There was also a substantial increase in the number of ionocytes (46%), suggesting that these two cell types are somehow linked in their development.

![**FoxA1 is a regulator of SSC development.** (A) The *foxa1* gene has two exons and one intron. An antisense morpholino oligo (red) was designed against the splice junction of exon 1 and intron 1. Loss of *foxa1* transcript is evident with *foxa1* MO compared with controls (MOC) by RT-PCR (using primers either side of the splice site), indicating knockdown of expression. A higher band was evident for the *foxa1* morphants, which is indicative of an unspliced transcript. There is no difference in the intensity of bands for the ubiquitously expressed gene *ornithine decarboxylase* (*ODC*). (B) Representative images of stage 32 embryos showing the frequency of each cell type after applying MOC or *foxa1* morpholino. Ciliated cells were marked by *α-1-tubulin*, SSCs by *itpkb*, ionocytes by *atp6v1a* and goblet cells by antibody to Xeel. The total number of cells in a defined area was determined by DAPI staining of nuclei and a ratio for each marker relative to the total number of cells was determined as shown in the chart. The mean ratio for ten embryos is shown for each sample. Error bars represent s.e.m. Student's *t*-test, *P*\<0.01 (^\*\*^). Scale bars: 50 μm.](DEV102426F5){#F5}

It is possible that SSCs are not properly specified in *foxa1* morphants. Alternatively, they may be correctly specified but undergo selective cell death early on. To distinguish these possibilities we examined the number of TUNEL-positive cells, together with an SSC marker (*itpkb*), at late neurula (stage 21) and late tailbud stage (stage 33) of *foxa1* morphant embryos. There was some increase in epidermal cell death at late tailbud stages, but at early stages *itpkb* expression was significantly reduced, even though there was no increase in cell death ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S4). Thus, the decrease in the SSCs upon *foxa1* knockdown is not primarily due to cell death.

Overexpression of *foxa1* had the opposite effect in that it increased the number of SSCs ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S5A). However, this was only evident at a low dose of overexpression (10 pg), whereas higher doses (\>50 pg) resulted in the appearance of 'masses' of PNA-negative, smaller cells ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S5B). This is consistent with previously suggested roles for FoxA1 in tumorigenesis ([@R37]; [@R41]; [@R59]).

*Foxa1* morphants are susceptible to bacterial infection {#S8}
--------------------------------------------------------

When looking for the phenotypic consequences of *foxa1* knockdown, we noticed that embryos showed a marked tendency to die shortly after hatching from the vitelline membrane ([Fig. 6A](#F6){ref-type="fig"}). The appearance of the embryo culture was reminiscent of bacterial infection, which occasionally happens, as we do not routinely supplement the medium with antibiotics. We therefore tested whether we can rescue the phenotype with antibiotics.

![**Depletion of SSCs leaves embryos susceptible to infection.** (A) Representative images showing embryo death following *foxa1* knockdown. Supplementing the media with the broad-spectrum antibiotic, gentamicin (20 μg/ml) leads to a greater level of survival. *n*=7 experiments. (B) Quantitation of the survival rate. Error bars represent s.e.m. Student's *t*-test, ^\*\*^*P*\<0.01. Scale bars: 2 mm.](DEV102426F6){#F6}

Embryos injected with control morpholino (MOC) showed excellent survival levels 2 days post-fertilisation (approximately stage 35-37), both with and without application of the broad-spectrum antibiotic, gentamicin (20 μg/ml; [Fig. 6A](#F6){ref-type="fig"}). However, *foxa1* morphants, 2 days post-fertilisation, showed much reduced survival levels when cultured in 0.01× Marc's modified Ringer's (MMR) solution alone. Upon application of gentamicin, significant rescue of the survival rate was evident ([Fig. 6A](#F6){ref-type="fig"}). Quantification of seven independent experiments ([Fig. 6B](#F6){ref-type="fig"}) reveals that supplementing the media in which *foxa1* morphants were reared with antibiotic led to an increase in survival rate from ∼27% to 80% (*P*\<0.01). This compares to over 90% survival for control embryos with or without antibiotic.

To exclude the possibility that the phenotype is due to the increase in ionocytes that accompanies *foxa1* MO injections (see [Fig. 5B](#F5){ref-type="fig"}), rather than the decrease in SSCs, we increased specifically the number of ionocytes by overexpression of *foxi1* ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S6A). This did not significantly affect the survival of the embryos (∼90% survival) in three independent experiments and there was no effect by the addition of antibiotics ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S6B).

Loss of SSCs could cause the death of the embryos by having a major effect on the integrity of the epidermis. To answer this question we analysed control and morphants embryos by membrane GFP expression. We have found no obvious difference from the controls at late neurula and tadpole stages, although we did notice an increased tendency of some epidermal cells to round up at the later stages of analysis. However, cell-cell contact appeared normal ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S7).

SSCs secrete glycosylated and oligomeric material of high molecular weight {#S9}
--------------------------------------------------------------------------

Given the protective action of the SSCs, we sought to identify components of the secretory material that are likely to account for this activity. As PNA recognises the material in the majority of the vesicles in the SSCs ([Fig. 4E](#F4){ref-type="fig"}), we used PNA-HRP as a reagent for further investigation. Two PNA-positive species above 100 kDa were observed when the cement gland was present, but only a single species when the cement gland was removed ([Fig. 7A](#F7){ref-type="fig"}, first four lanes). Comparing cement gland lysate and material aspirated directly from the epidermal surface confirmed that the species running lower in the gel corresponds to epidermal secretions and the material higher in the gel to the cement gland secretions ([Fig. 7A](#F7){ref-type="fig"}, last two lanes). Comparing unreduced (-DTT) and reduced (+DTT) secretions from wild type without cement gland (WT - CG) embryos showed that the reduced samples migrate further in the gel ([Fig. 7B](#F7){ref-type="fig"}). This indicates that the native PNA-positive material can form oligomers (and potentially polymers) through disulphide bonding. A comparison of secretions from *foxa1* morphants and controls showed a substantial decrease in the PNA-positive material corresponding to epidermal secretions ([Fig. 7C](#F7){ref-type="fig"}, red arrow). There was little difference in the band corresponding to the cement gland material ([Fig. 7C](#F7){ref-type="fig"}, blue arrow).

![**SSCs secrete mucin-like molecule(s).** (A) Lectin blot for PNA conjugated to horseradish peroxidase (PNA-HRP) of an agarose gel loaded with samples (reduced and alkylated). Secretions from wild-type embryos with cement gland (WT + CG), put through a filter to remove species with molecular weight lower than 100 kDa, shows two bands positive for PNA (blue and red arrows). For secretions from wild-type embryos with cement gland excised (WT - CG), there is only a single band evident (red arrow). Cement gland lysate alone gave predominantly the upper band, whereas aspirating directly from the skin gave predominantly the lower band. (B) Lectin blot for PNA-HRP of unreduced (-DTT) and reduced (+DTT) samples taken from secretions of wild-type embryos with cement gland removed. Reduced samples migrate much further in the gel. (C) Lectin blot for PNA-HRP comparing levels of PNA positive material secreted into the media in control and *foxa1* morpholino-injected embryos. There is a clear reduction in the lower band (red arrow), whereas the upper band (blue arrow) is of a similar level. (D) Chart showing results of CsCl density gradient centrifugation on samples obtained from the media of embryos with cement gland excised. Fractions of decreasing density were harvested and tested for PNA-reactivity in slot blots. Intensity measurements for PNA reactivity were recorded for each fraction and plotted as shown. (E) Timecourse of *otogelin-like* mRNA *in situ* hybridisation shows epidermal staining at four stages. There is strong staining in the SSCs at stage 32 (zoom, inset). (F) *Otogelin-like* (green) *in situ* hybridisation combined with PNA-Alexa-568 (red) staining, at stage 32, shows colocalisation in SSCs and goblet cells (at a lower level). Lower image is a magnification of the area in the box of the upper image. Scale bars: in E, 100 μm and 10 μm (stage 32 image, inset); in F, 100 μm (upper) and 20 μm (lower).](DEV102426F7){#F7}

The apparent properties of high molecular weight, glycosylation and formation of oligomers through disulphide bonding is reminiscent of mucin glycoproteins. Mucins can be isolated based on their density, so to further enrich the PNA-positive material secreted from the epidermis we separated the samples using caesium chloride (CsCl) density gradient centrifugation. The chart in [Fig. 7D](#F7){ref-type="fig"} shows a peak of PNA reactivity for fractions of density 1.3-1.4 g/ml, which is similar to the density of known mucins ([@R52]). PNA-positive fractions were pooled and analysed by mass spectrometry, alongside samples taken before purification from embryos with and without cement gland, to identify any active components.

Mass spectrometry analysis of epidermal secretions identifies glycosylated and oligomeric molecules and other proteins involved in innate immunity {#S10}
--------------------------------------------------------------------------------------------------------------------------------------------------

[Table 1](#T1){ref-type="table"} summarises the top protein hits in mass spectrometry for the three sets of samples. One of the top hits in all three samples was a predicted protein, LOC100496483, which matched to a locus in the *X. tropicalis* genome ([@R18]). This protein appears most closely related (70% identity at the amino acid level) with a glycoprotein called Otogelin described in *X. laevis* ([@R17]), so we called this protein Otogelin-like. As this protein gave the highest hit after purification by density gradient centrifugation and pooling PNA fractions, we postulated that this is the molecule recognised by PNA and secreted from the epidermis. To test this notion we generated an RNA probe to the *otogelin-like* transcript and observed its expression pattern at different stages of development ([Fig. 7E](#F7){ref-type="fig"}). At stage 20, *otogelin-like* is expressed principally in the goblet cells, but by stage 32, there is strongest staining in the SSCs ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S8A) and a lower level in goblet cells and ionocytes, but not in the ciliated cells ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S8B-D). However, by stage 42 the expression of *otogelin-like* is almost completely confined to the SSCs. [Figure 7F](#F7){ref-type="fig"} shows that the *otogelin-like* transcript has an overlapping expression pattern with PNA and this is particularly prominent in the SSCs.

###### 

***Xenopus* mass spec hits for protein in different samples**

![](DEV102426TG1)

To test the effect of *otogelin-like* depletion, we knocked it down using MO injections ([Fig. 8A](#F8){ref-type="fig"}). Although in morphant embryos, there was a clear reduction in PNA staining ([Fig. 8B](#F8){ref-type="fig"}) and an alteration in the morphology of secretory vesicles of goblet cells and SSCs by TEM ([Fig. 8C](#F8){ref-type="fig"}), the viability of the embryos was normal until at least advanced tadpole stage (stage 42; data not shown). At that point, embryos showed swelling and eventually died, but this was not rescuable by antibiotics (data not shown). Together with earlier data, these results strongly suggest that the dense, oligomeric glycoprotein marked by PNA; secreted from the epidermis and reduced upon SSC depletion is the Otogelin-like species. However, knockdown of *otogelin-like* alone is not sufficient to phenocopy the *foxa1* morphants.

![**Impact of *otogelin-like* knockdown on the epidermis.** (A) The *otogelin-like* gene is predicted to have up to 79 exons and 78 introns. An antisense morpholino oligo (red) was designed against the splice junction of exon 1 and intron 1. Loss of *otogelin-like* transcript is evident with *otogelin-like* MO compared with controls (MOC) by RT-PCR, indicating knockdown of expression. There is little difference in the intensity of bands for the ubiquitously expressed gene, *ornithine decarboxylase* (*ODC*). (B) Comparison of PNA staining in otogelin-like morphants compared with controls (MOC). Right panels are higher magnification images of the flank epidermis. (C) TEM images of goblet cells and SSCs in controls (MOC) and *otog-like* MO treated embryos. Note absence of dark core in the vesicles of the SSCs. Scale bars: in B, 250 μm (left panels) and 50 μm (right panels); in C, 1 μm.](DEV102426F8){#F8}

Of the other hits in mass spectrometry, the IgGF~c~γ binding protein (Fcgbp) was also found in the purified samples, which is interesting because it has been identified previously in intestinal mucus samples ([@R22]). One predicted mucin, Muc5e, was identified but only in the WT+CG sample, indicating that it is secreted from the cement gland, which we confirmed by *in situ* hybridisation for *muc5e* ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1) Fig. S3B). Other interesting proteins present in the material before purification include two complement factors as well as the glycolipoproteins, vitellogenin and apolipoprotein B, which are implicated in innate immunity ([@R39]; [@R64]). It remains to be seen whether any of these candidates are secreted from epidermal cells, in particular the SSCs, and whether they contribute to innate immunity.

DISCUSSION {#S11}
==========

Using a combination of markers for the known epidermal cell types, new markers and ultrastructural analyses we have characterised a new cell type, the SSCs, in the *Xenopus* larval epidermis. With the characterisation of these secretory cells, all the cell types in the epidermis up to tadpole stages are accounted for. This is an important step in being able to fully utilise this system as a simple model to study the development and function of mucociliary epithelia and the interactions between cell types.

There has been some confusion in the literature as to the true identity of these cells. The fact that they are nonciliated, undergo an intercalation event and have a scattered epidermal distribution had led many, including ourselves, to assume that these cells are ionocytes ([@R8]; [@R40]). Indeed, many of the gene markers for ionocytes and SSCs have been grouped together as being part of one cell type ([@R17]). Our current study addresses this issue and shows that the SSCs are indeed a distinct cell type.

The transcription factor Foxa1 was found to be integral for the development of the SSCs. It is of note that this same transcription factor has been shown to be crucial in the development of numerous secretory cell types in mammals, including goblet cells and clara cells in the lung, and enteroendocrine cells in the gut ([@R2]; [@R12]; [@R60]). In addition, Foxa1 has also been shown to directly transactivate expression of mucin genes ([@R23]; [@R56]). Together with our results, these findings suggest an evolutionarily conserved role of FoxA1 genes in regulating secretory cell fate in epithelial tissues.

Embryos that develop without SSCs, achieved by knocking down Foxa1, die around hatching, at a time that is coincident with SSC intercalation into the outer layer. We were able to rescue embryos from dying by the addition of antibiotics into the media, indicating that these cells provide a first line of defence against infection. We suggest that there are at least three ways by which SSCs may protect the embryo from infection.

First, SSCs may protect the epidermis from invasion by producing a mucus layer, which can trap bacteria and other particulate material and exclude its entry to the underlying epithelium. The major structural components of mucus are large, polymeric gel-forming glycoproteins called mucins ([@R54]). Our EM data showed that the vesicles of SSCs contain dense material that visually resemble mucins in mammalian goblet cells ([@R58]). However, our extensive analysis of secretions did not identify any of the predicted mucins in the *X. tropicalis* genome, despite the fact that there are at least 25 ([@R28]). Indeed, as far as we are aware, the only embryonic mucin with known expression in *Xenopus* is our identification of Muc5e, which is produced by the cement gland. This is in contrast to the adult frog skin, where putative mucins have been identified in subdermal mucous glands and are thought to be secreted onto the surface of the skin ([@R16]; [@R43]).

Our screen did, however, identify another glycoprotein, Otogelin-like, which has characteristics of mucins. The otogelins are evolutionarily related to mucins, with both containing von Willebrand factor (vWF) domains and cysteine knot domains that facilitate disulphide bonding of monomers to generate large polymers ([@R28]). Otogelin has been identified in fibre-like structures in the acellular membranes of the inner ear in mammals including humans ([@R4]; [@R5]), and mutations in the *OTOG* gene can result in deafness ([@R42]). The fact that Otogelin-like is glycosylated and able to form oligomers suggests that it is capable of forming the matrix of a mucus-like barrier over the surface of the embryo. We suggest that the Otogelin-like protein can undergo massive expansion once it is secreted to form a layer over the surface, just like mucins do ([@R25]). However, our knockdown experiments suggest that this Otogelin-like protein is not sufficient on its own to mediate anti-microbial defence of the epidermis and that there are likely to be other secreted molecules. Indeed, our EM analysis shows that some secretory material (of unknown identity) remains in the SSCs, even once Otogelin-like is knocked down ([Fig. 8C](#F8){ref-type="fig"}).

Identification of the IgGFcγ-binding protein (FCGBP) is also interesting in terms of the generation of a mucus layer because it has been found to be covalently associated with the mucin Muc2 in the intestines of mice ([@R22]). It also has many vWF domains, and has been postulated to cross-link mucins, adding stability to the mucus layer. It has also been shown to interact with other molecules in mucus, including the trefoil factors ([@R1]). Thus, FCGBP could also contribute to a mucus layer on the surface of the tadpole skin, although further tests are needed to confirm this.

A second possible way in which SSCs could provide protection against infection is to secrete innate defence and anti-infective molecules onto the surface. Adult frogs are known to secrete a potent cocktail of antimicrobial peptides (AMPs) onto the skin, including the magainins, from subdermal granular glands ([@R48]; [@R62]). However, these AMPs have never been isolated in tadpoles before metamorphosis despite several attempts to do so ([@R63]). So how do the tadpoles protect themselves? Candidates in our mass spectrometry screen may give some clues. Some of our top hits were for the glycolipoproteins vitellogenin and apolipoprotein B. Vitellogenin is most commonly known as an egg yolk precursor protein that provides the energy source for developing embryos ([@R24]). However, it has also been shown to have additional roles in innate immunity ([@R64]). It has active antibacterial activity as well as the ability to recognise bacterial structures and promote phagocytosis ([@R30]; [@R55]). Vitellogenin has also been identified as an antimicrobial agent in fish mucus ([@R32]; [@R44]). Meanwhile, apolipoprotein B has been shown to antagonise and inhibit expression of invasive genes by *Staphylococcus aureus* and mice deficient for apolipoprotein B are more susceptible to infection ([@R39]). The identification of the complement proteins, C3 and C9, in our mass spectrometry analysis is also of note because the complement cascade is a well-known innate defence system ([@R10]; [@R21]). Perhaps some of these molecules are secreted from the SSCs in addition to Otogelin-like. Thus, as summarised in our model in [Fig. 9](#F9){ref-type="fig"}, antimicrobial defence may be due to the combinatorial action of a number of molecules.

![**Overview of *Xenopus* epidermal cell types and secretions.** The epidermis of late tailbud/tadpole embryos has four cell types: ciliated cells, ionocytes, goblet cells and small secretory cells. Otogelin-like is a major secretory glycoprotein secreted from goblet cells and SSCs. Goblet cells also secrete the lectin, Xeel. SSCs also secrete another granular material in their vesicles that has yet to be identified. Other innate defence molecules found in secretions include vitellogenin, apolipoprotein b, complement factors (C3 and C9) and FCGBP/FCGBP-like proteins.](DEV102426F9){#F9}

Finally, another contributor to the phenotype of enhanced susceptibility to infection could be an indirect effect of depleting SSCs on neighbouring cells. The accompanying paper by Walentek et al. describes how secretion of serotonin from the SSCs enhances the beating of cilia in adjacent ciliated cells ([@R57]). In the absence of SSCs, the lack of serotonin could reduce ciliary beating and affect clearance of the mucus-like substance, leading to conditions where pathogens can thrive and infect the epidermis.

Through the initial characterisation of these cells, we have opened up the possibility for future studies into their role in innate immunity as well as other unexplored functions. The resemblance with the mucociliary epithelium of the respiratory tract is striking, and these similarities make the *Xenopus* larval skin a potentially very powerful model to study development, function and breakdown of these important epithelia.

MATERIALS AND METHODS {#S12}
=====================

Morpholino design {#S13}
-----------------

All morpholinos were purchased from Gene Tools. The sequence of the *foxa1* splice morpholino is 5′-GGATTCCTTCTCTTACCTCCTGGGT-3′. The *otogelin-like* splice morpholino sequence is 5′-TAGAGTCATACATACCTCCATCATC-3′. The control morpholino has the sequence 5′-CCTCTTACCTCAGTTACAATTTATA-3′. Morpholinos were injected with a 15 ng dose at the one-cell stage unless otherwise stated.

Constructs and RNA generation {#S14}
-----------------------------

Constructs for generating probes were obtained from expressed sequence tag (EST) clones in the *Xenopus* full-length database ([@R14]). The clone names were as follows: *atp6v1a* (TTpA014f09), *α-1-tubulin* (TNeu122k16), *otogelin-like* (THdA045k18), *foxa1* (TNeu062i17), *itpkb* (XM_002938844), *foxi1* (TNeu069d21), *foxj1* (TNeu058m03) and *muc5e* (TTbA069h06). The constructs were linearised and transcribed with T7 RNA polymerase (Promega) to generate antisense RNA probes. The probes were labelled with fluorescein isothiocyanate (FITC), digoxygenin (Dig) or dinitrophenol (DNP). *In vitro* transcription was employed to generate *GAP43-GFP* mRNA from a pCS2-GAP43-GFP construct for injection into embryos and to mark membranes ([@R26]). The construct was linearised with *Not*I and transcribed with SP6 RNA polymerase (Promega).

Whole-mount chromogenic and fluorescence *in situ* hybridisation {#S15}
----------------------------------------------------------------

Chromogenic *in situ* hybridisation was carried out as described ([@R15]). Multicolour fluorescence *in situ* hybridisation was performed using tyramide amplification after addition of probes and antibodies conjugated to horseradish peroxidase ([@R29]).

Immunofluorescence and lectin fluorescence {#S16}
------------------------------------------

Immunofluorescence was largely carried out as described previously ([@R8]; [@R9]). All primary antibodies for immunofluorescence were used at a dilution of 1:1000. Secondary antibodies (Invitrogen) conjugated to fluorophores were used at a dilution of 1:500. The following primary antibodies were used: mouse anti-acetylated α-tubulin (T7451; Sigma), rabbit anti-V1a (ST170; a gift from Shigeyasu Tanaka, Shizuoka University, Japan), mouse-anti-Xeel (a gift from Saburo Nagata, Japan's Women's University, Tokyo, Japan), mouse anti-HNK-1 antibody (C6680; Sigma), rabbit anti-GFP antibody (A-6455; Life Technologies) and a custom-made rabbit anti-Itpkb antibody (Cambridge Research Biochemicals, UK). The lectin, PNA conjugated to Alexa Fluor 568 (Life Technologies), was used at a dilution of 1:1000.

Epidermal transplantation {#S17}
-------------------------

Embryos were injected with the fluorophores MR, FLDX or CB (all Invitrogen), at the eight-cell stage in two ventral blastomeres fated to become epidermal tissue. The embryos were reared in 0.01× MMR until gastrulation and then transferred to transplantation buffer \[0.5× MMR, 1% Ficoll and 5 μg/ml gentamicin (Sigma)\]. Tungsten wires were used to remove a section of outer layer epidermis from one set of fluorophore-injected embryos. A section of outer layer tissue from a different set of fluorophore-injected embryos was then transplanted onto the inner layer of the first set and the embryos were left for 2 hours to heal. The embryos were then transferred to post-transplantation buffer (0.1× MMR, 5 μg/ml gentamicin) and reared until stage 32, when they were fixed for analysis.

TUNEL staining {#S18}
--------------

The TUNEL protocol on *Xenopus* embryos was performed largely as described previously ([@R19]). In summary, embryos were fixed in MEMFA and stored in methanol. Embryos were bleached (70% methanol, 10% H~2~O~2~, 5% formamide) to remove pigment and then rehydrated into PBS. Embryos were incubated in 150 U/ml terminal deoxynucleotidyltransferase (Invitrogen) and digoxygenin-dUTP (1:1000, Roche). Reaction was terminated with 1 mM EDTA in PBS. The normal *in situ* hybridisation protocol was then followed using anti-digoxygenin antibody conjugated to alkaline phosphatase and chromogenic reaction using nitro-blue tetrazolium chloride/5-bromo-4-chloro-3′-indolyphosphate p-toluidine salt (NBT/BCIP) as a substrate ([@R15]).

Collection of embryonic secretions {#S19}
----------------------------------

Embryos were reared in 0.01× MMR for 24 hours until stages 22-24 and then, if required, cement glands were removed with forceps in 0.01× MMR + gentamicin (10 μg/ml). Embryos were then reared until stage 35. To get enough material, 300 embryos were packed into a well containing 600 μl of media. The embryos were reared for 4 hours at room temperature with agitation every 20 minutes. Embryos were then anaesthetised with tricaine and the media removed for analysis of secretions. Material was also aspirated directly from the epidermis using glass Pasteur pipettes. Denaturants such as 6 M urea or 8 M guanidinium chloride were added to denature any proteins. If required, samples were reduced in 10 mM dithiothreitol (37°C for 1 hour) and alkylated in 25 mM iodoacetamide (30 minutes at room temperature in the dark). To concentrate the secretory material, the media samples were centrifuged through Vivaspin columns (Sartorius Stedim Biotech) that trap material above a certain molecular weight. We used filters with a 100,000 MW cut-off so any material above this size was retained.

Agarose gel electrophoresis and PNA lectin blot {#S20}
-----------------------------------------------

Agarose gels are used to separate high molecular weight and highly charged molecules such as mucins. Agarose gels were made at 1% (w/v) in tris-acetate-EDTA (TAE). Samples were loaded and electrophoresed at 65 V for 4-6 hours. After separation, proteins were vacuum blotted on to nitrocellulose membranes for 90 minutes in 4× SSC. PNA conjugated to horseradish peroxidase (PNA-HRP, Sigma) was applied to the membranes at a dilution of 1:1000 for two hours. The membranes were then washed four times for 5 minutes each in TBS-Tween, reacted with chemiluminescence reagents (Sigma), and exposed to photographic film (Kodak).

Caesium chloride density gradient centrifugation {#S21}
------------------------------------------------

Collected samples were separated by CsCl/4 M guanidinium chloride density gradient centrifugation ([@R53]). The starting density was 1.4 g/ml and a Beckman Ti70 rotor was used to generate the gradient in an ultracentrifuge at 164,685 ***g*** for 68 hours at 15°C. Fractions (0.5 ml) were taken and assessed for PNA reactivity and density. Positive fractions were pooled, reduced and alkylated, and concentrated on Vivaspin columns before mass spectrometry.

Mass spectrometry {#S22}
-----------------

Samples were exchanged into 2 M urea (50 mM ammonium bicarbonate) using Vivaspin columns and digested overnight in trypsin (1 μg, Sigma). The tryptic peptides were purified using ZipTips (Millipore) and solubilised in 0.1% formic acid. Tryptic peptides were separated by reverse phase liquid chromatography (LC) and analysed by tandem mass spectrometry (LC-MS/MS) using a NanoAcquity LC (Waters, Manchester, UK) coupled to a LTQ Velos mass spectrometer (Thermo Fisher Scientific). MS/MS data were searched using Mascot 2.4 (Matrix Science, UK) software against a custom database consisting of the SWISSPROT database with additional predicted *Xenopus tropicalis*-specific mucin sequences ([@R28]). The parameters were as follows: Carbamidomethyl (C) as fixed modification, Oxidation (M) as variable modification, peptides mass tolerance of 1.2 Da, fragments mass tolerance 0.6 Da, 1 missed cleavage maximum.

Electron microscopy {#S23}
-------------------

SEM and TEM were performed according to standard protocols. For SEM, embryos were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) and then postfixed in osmium tetroxide. Embryos were then critical point dried and sputter-coated with gold. Imaging was performed on an FEI Model Quanta 200 ESEM. For TEM, embryos were fixed overnight in 2% formaldehyde + 2% glutaraldehyde in 0.1 M cacodylate and then post-fixed in reduced osmium. The embryos were then put in 1% tannic acid and then 1% uranyl acetate, for 1 hour each. Samples were then dehydrated in ethanol and embedded in low viscosity resin. Sections of 70 nm were cut on a Reichert-Jung Ultracut E ultramicrotome and observed using an FEI Tecnai 12 electron microscope at 80 kV.

Supplementary Material
======================

###### Supplementary Material

We thank staff in the EM facility in the Faculty of Life Sciences, University of Manchester, for their assistance, and the Wellcome Trust for equipment grant support to the EM facility; Aleksandr Mironov, Leslie Lockey and Patrick Hill for assistance with EM; Raphael Thuret for help with collection of samples and Bethan Powell for assistance with *in situ* hybridisation; Saburo Nagata and Shigeyasu Tanaka for donation of antibodies; Martin Blum for sharing data and reagents prior to publication; and Kristian Franze for some help in the early stages of analysis of the phenotype.

**Competing interests**

The authors declare no competing financial interests.

**Author contributions**

E.D., K.R., R.L., X.S. and S.N. performed the experiments. E.D., K.R., D.J.T. and N.P designed the experiments. The manuscript was written by E.D. and N.P., and edited by E.A., A.S. and D.J.T.

**Funding**

This work was supported by a Wellcome Trust Senior Research Fellowship \[WT 090868Z/09/Z to N.P.\]; a Wellcome Trust Institutional Strategic Support Fund grant \[097820/Z/11/Z to N.P. and E.D.\]; core funding to the Wellcome Trust Centre for Cell-Matrix Research \[WT 088785/Z/09/Z\]; and a Medical Research Council grant \[G1000450 to D.J.T\]. Deposited in PMC for immediate release.

**Supplementary material**

Supplementary material available online at <http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.102426/-/DC1>
